Stefanie Gross-Layh

Stefanie Gross-Layh is a seasoned medical professional with extensive experience in clinical and translational research, particularly in immuno-oncology and medical science liaison roles. Currently serving as a Medical Science Liaison for Achondroplasia at BioMarin Pharmaceutical Inc. since January 2023, Stefanie previously held a similar position at Linical from September 2021 to December 2022, representing BioMarin. Prior to these roles, an impactful tenure of over a decade as a Scientific Group Leader in the Department of Dermatology at Universitätsklinikum Erlangen involved leading clinical trials and developing novel immunotherapy strategies. Training includes a Ph.D. in Biochemistry from Freie Universität Berlin and a postdoctoral position focused on immunomonitoring. Additional qualifications comprise a diploma in biochemistry and a certificate in MSL/Medical Management from Pharmaakademie.